WebMar 31, 2024 · Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product ... WebDec 31, 2024 · Fiscal Year End for CanFite Biopharma Ltd falls in the month of December. All data in Millions except Per Share data. Cash Flow From Operations, Investments & Financial Activities
CanFite Biopharma (CANF) Price To Cash Flow - Zacks.com
WebSep 17, 2015 · Can-Fite Biopharma started at buy with $9 stock price target at Alliance Global MarketWatch. Tuesday, September 10, 2024. 08:11 AM ET. Can-Fite's stock soars on heavy volume after collaboration deal with … WebHere is how CanFite Biopharma Ltd (CANF) and Cellectar Biosciences, Inc. (CLRB) have performed compared to their sector so far this year. Jan. 17, 2024 at 9:40 a.m. ET on Zacks.com optimum no rinse with wax
DJIA Dow Jones Industrial Average Overview MarketWatch
WebWho invested in CanFite BioPharma? CanFite BioPharma has 5 investors including Cybele Holdings and Cybele Holdings. How much funding has CanFite BioPharma raised to date? CanFite BioPharma has raised $80.4M. When was the last funding round for CanFite BioPharma? CanFite BioPharma closed its last funding round on Aug 12, … WebCan-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and … Can-Fite Biopharma Ltd. ADR company facts, information and financial ratios … Can-Fite Biopharma Ltd. ADR analyst estimates, including CANF earnings per … WebMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for CanFite Biopharma (CANF) portland press hald